Jim Cramer: This Tech Stock Is 'Great,' Archer Aviation Is 'Too Speculative For Me'

Comments
Loading...
Zinger Key Points

On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc HZO. "It's just too risky right here," he noted.

On March 11, MarineMax announced a new stock repurchase program of up to $100 million.

Trade Desk Inc TTD is "great," Cramer said.

On Feb. 15, Trade Desk reported better-than-expected fourth-quarter revenue results.

The "Mad Money" host recommended selling Peabody Energy Corp BTU, adding, "I’m not a coal guy."

On Feb. 8, Peabody Energy posted weaker-than-expected fourth-quarter earnings.

Cramer said Geron Corp GERN is "just ok. I mean, we’ve got so many great biotechs these days." He recommended sticking with the "good ones."

On March 14, Geron Co announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted in favor of the clinical benefit/risk profile of imetelstat for the treatment of transfusion-dependent anemia.

Archer Aviation Inc ACHR is losing a lot of money, Cramer said, "It’s just too speculative for me."

On Feb. 26, Archer Aviation reported worse-than-expected fourth-quarter financial results.

Cramer said he likes Uranium Energy Corp. UEC.

On March 25, Uranium Energy reported the appointment of Brent Berg as Senior Vice-President, U.S. Operations.

Price Action:

  • MarineMax shares fell 6.4% to settle at $27.50 on Wednesday.
  • Uranium Energy shares gained 3.4% to close at $7.13.
  • Peabody Energy shares gained 0.3% to close at $23.57 during Wednesday’s session.
  • Shares of Trade Desk fell 0.5% to close at $86.44 on Wednesday.
  • Geron shares rose 0.3% to settle at $3.44 on Wednesday.
  • Archer Aviation shares fell 2.8% to close at $4.16.

Read Next: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!